Evidence map›Paper›PMID 40516488›Full record

ArticleVirology2025

A targeted genetic screen identifies Caenorhabditis elegans genes involved in RNAi-independent antiviral defense.

Mingli Xia, Teng Yan, Rui Lu

Abstract read
In one paragraph

Article in Virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mingli XiaDepartment of Biological Sciences, Louisiana State University, Baton Rouge, LA, 70803, USA.
Teng YanDepartment of Biological Sciences, Louisiana State University, Baton Rouge, LA, 70803, USA.
Rui LuDepartment of Biological Sciences, Louisiana State University, Baton Rouge, LA, 70803, USA. Electronic address: ruilu@lsu.edu.

Funding

In-depth study of antiviral RNA silencing in Caenorhabditis elegansR01GM119012 · NIGMS · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI LU, RUI · 2017 to 2021
$1.4M
Negative regulation of human antiviral RNAi by PACTR03AI171860 · NIAID · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI LU, RUI · 2023 to 2024
$148k
NIAID NIH HHS R03 AI171860NIGMS NIH HHS R01 GM119012
6 · The paper itself

Abstract

Cellular organisms are constantly challenged by potentially lethal viral infections and rely on diverse antiviral mechanisms for survival. In several systems, including plants and insects, parallel antiviral pathways provide redundancy, ensuring host protection even if one pathway is compromised by a virus. However, whether such alternative antiviral mechanisms exist in nematodes beyond RNA interference (RNAi) remains largely unexplored. To address this question and as proof of principle, we conducted a small-scale genetic screen to identify C. elegans genes involved in RNAi-independent antiviral defense (RiAD). The reporter system for this screen was a combination of a GFP-tagged flock house virus replicon, as the readout of efficient viral replication, and an RNAi-deficient triple mutant. The reporter C. elegans strain also carried a recessive E3 allele, which suppresses the replication of both flock house virus and Orsay virus. Because this reporter strain lacks a functional RNAi response, any restoration of viral replication in the screen is unlikely due to RNAi disruption, thereby enriching for mutants with defects in RiAD. Upon completing this biased genetic screen we identified ten recessive alleles which were assigned to eight candidate genes. Notably, five of these genes also contributed to RiAD against Orsay virus, indicating a role in broad-spectrum natural antiviral defense. Strikingly, removal of the E3 allele in one of the mutant backgrounds resulted in lethal Orsay virus infection, suggesting that RiAD plays a critical role in protecting C. elegans from fatal viral infection in the absence of RNAi under natural conditions.

Indexed as

Caenorhabditis elegansCaenorhabditis elegans ProteinsHost-Pathogen InteractionsNodaviridaeRNA InterferenceAnimalsGenetic TestingVirus ReplicationCaenorhabditis elegans ProteinsAntiviral defenseC. elegansForward genetic screenMutagenesisRNAi

Identifiers

PMID40516488
PMCPMC12240484

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.